𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical relevance of CD95 (Fas/Apo-1) on T cells of patients with B-cell chronic lymphocytic leukemia

✍ Scribed by Claudia Groneberg; Tilman Pickartz; Alexander Binder; Frauke Ringel; Stefanie Srock; Thomas Sieber; Dagmar Schoeler; Folke Schriever

Book ID
114217033
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
117 KB
Volume
31
Category
Article
ISSN
0301-472X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical relevance of Fas (APO-1/CD95) e
Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma
✍ Martin C. JΓ€ckel; Christina Mitteldorf; Stefan Schweyer; LΓ szlΓ² FΓΌzesi πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 370 KB

## Background: Expression of fas receptors renders tumor cells potentially susceptible to the host immune system. in squamous cell carcinomas of the head and neck, fas has recently been found to be down-regulated in some cases; its prognostic value and correlation with clinicopathologic parameters,

Clinical relevance of the expression of
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia
✍ Sherif Ibrahim; Iman Jilani; Susan O'Brien; Anna Rogers; Taghi Manshouri; Franci πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 532 KB

## Abstract ## BACKGROUND CD31 (platelet endothelial cell adhesion molecule‐1 [PECAM‐1]) is the ligand for CD38, a transmembrane glycoprotein that is expressed on the surface of leukemic cells in many patients with B‐cell chronic lymphocytic leukemia (B‐CLL). In a previous study, the authors showe